Q1 EPS Estimates for Encompass Health Cut by Zacks Research

Encompass Health Co. (NYSE:EHC) – Research analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for shares of Encompass Health in a research note issued on Thursday, February 20th. Zacks Research analyst Z. Masood now forecasts that the company will earn $1.19 per share for the quarter, down from their previous estimate of $1.23. The consensus estimate for Encompass Health’s current full-year earnings is $4.80 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.13 EPS, FY2025 earnings at $4.67 EPS, Q1 2026 earnings at $1.30 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.21 EPS, FY2026 earnings at $5.19 EPS and FY2027 earnings at $5.67 EPS.

Other analysts have also issued reports about the company. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Barclays raised their price objective on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Up 1.4 %

EHC stock opened at $98.86 on Monday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The stock has a market capitalization of $9.96 billion, a price-to-earnings ratio of 22.17, a PEG ratio of 2.31 and a beta of 0.90. The business’s fifty day moving average price is $96.01 and its two-hundred day moving average price is $96.05. Encompass Health has a fifty-two week low of $73.68 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. bought a new stake in shares of Encompass Health during the 4th quarter valued at $152,953,000. Norges Bank bought a new position in shares of Encompass Health during the 4th quarter valued at about $100,637,000. Raymond James Financial Inc. purchased a new stake in Encompass Health during the 4th quarter valued at about $77,944,000. Point72 Asset Management L.P. boosted its holdings in Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after acquiring an additional 835,135 shares during the period. Finally, Jennison Associates LLC purchased a new stake in Encompass Health during the 4th quarter valued at about $52,094,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. Encompass Health’s dividend payout ratio is 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.